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Quantitative assessment of 
individual populations within 
polymicrobial biofilms
Susana Patrícia Lopes1, Nuno Filipe Azevedo2 & Maria Olívia Pereira1
Selecting appropriate tools providing reliable quantitative measures of individual populations in 
biofilms is critical as we now recognize their true polymicrobial and heterogeneous nature. Here, 
plate count, quantitative real-time polymerase chain reaction (q-PCR) and peptide nucleic acid probe-
fluorescence in situ hybridization (PNA-FISH) were employed to quantitate cystic fibrosis multispecies 
biofilms. Growth of Pseudomonas aeruginosa, Inquilinus limosus and Dolosigranulum pigrum was 
assessed in dual- and triple-species consortia under oxygen and antibiotic stress. Quantification 
methods, that were previously optimized and validated in planktonic consortia, were not always in 
agreement when applied in multispecies biofilms. Discrepancies in culture and molecular outcomes 
were observed, particularly for triple-species consortia and antibiotic-stressed biofilms. Some 
differences were observed, such as the higher bacterial counts obtained by q-PCR and/or PNA-FISH 
(≤4 log10 cells/cm2) compared to culture. But the discrepancies between PNA-FISH and q-PCR data (eg 
D. pigrum limited assessment by q-PCR) demonstrate the effect of biofilm heterogeneity in method’s 
reliability. As the heterogeneity in biofilms is a reflection of a myriad of variables, tailoring an accurate 
picture of communities´ changes is crucial. This work demonstrates that at least two, but preferentially 
three, quantification techniques are required to obtain reliable measures and take comprehensive 
analysis of polymicrobial biofilm-associated infections.
In most natural scenarios, including in infectious diseases, microorganisms assemble in dynamic communities 
and persist within high spatially structured consortia, known as biofilms1,2. Such living structures display unique 
properties, providing strong benefits to their constituent species (e.g. enhanced resistance to antimicrobial ther-
apy, protection towards host immunity, better adaptation to hostile surrounding conditions)3–5. The recognition 
that most biofilms present a spatiotemporal heterogeneous chemical, physiological and genetic composition6,7 
and typically comprise multiple species8 poses a serious concern in health care regarding the synergies that 
arise from the residing species that generally turn infections more severe and recalcitrant to treatment5,9,10. This 
highlights the need for reliable technologies that comprehensively diagnose polymicrobial biofilm infections, 
by clearly addressing each individual member in the community, for accurate and timely therapeutic decisions.
Traditional diagnosis of biofilm-associated infections has relied on culture-based approaches to identify 
the aetiological agents, as well as to ascertain for the most abundant members11–14. Conventional techniques 
are, however, time-consuming and frequently lead to false-negative results, for numerous reasons: they require 
appropriate selective media, microbiological techniques and optimal growth conditions for an accurate detection/
identification; antibiotic-treated bacteria are, in most cases, below the detection limit of culture12; “viable but non-
culturable” (VBNC) bacteria are often evaded from detection, since a great percentage (>70%) of microorganisms 
inhabiting human body surfaces are not readily cultured in vitro15–17. Importantly, bacteria encased in biofilms are 
notoriously difficult to culture or even grow poorly on agar plates18. Under these circumstances, standard micro-
biological methods are often ill-suited to diagnose polymicrobial biofilm infections19 and underscore the reason 
that clinicians struggle to manage these infections with culture-independent tools20–23. Quantitative real-time 
polymerase chain reaction (q-PCR) has been the “gold standard” in clinic, affording a rapid screening and quan-
tification of specific organisms in biofilm samples that are unable to be detected by cultivation24–26. Fluorescence 
in situ Hybridization (FISH) using peptide nucleic acid (PNA) probes (i.e. PNA-FISH) has also been evidenced 
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as an attractive molecular tool with regard to a rapid identification of medically relevant species in a variety of 
polymicrobial contexts27–33. Rapid technological advances hold promises, however the multiple bacteria residing 
in a biofilm, typically possessing distinct behaviours, phenotypes, physiological/metabolic states, might com-
promise the reliability of molecular methods in biofilms34–38. While the mechanisms underpinning the level of 
heterogeneity generated in the biofilm – which is in a large extent a reflection of a myriad of variables (e.g. antibi-
otic administration39; the physicochemical characteristics of the local microenvironment7,40) - are not completely 
exploited, selecting appropriate tools that give robust measures of the community changes has potential clinical 
significance for opportunities for therapeutic breakthroughs.
This work aims to employ and compare culture (plate count) and molecular (q-PCR and PNA-FISH) 
approaches to quantitatively assess individual populations in mixed-species biofilms. As a case-study, a defined 
polymicrobial consortia involving phylogenetically diverse bacterial strains related with cystic fibrosis (CF) infec-
tions were used. Specifically, Pseudomonas aeruginosa was assessed, in two- and triple-species biofilms, with the 
CF lesser common species Inquilinus limosus and Dolosigranulum pigrum, under environments with distinct 
oxygen availabilities (aerobic, AER; microaeropilic, MAER; and anaerobic, ANAER) and following antibiotic 
intervention.
Results and Discussion
CF lung has long been pointed out as the major site of infection mediated by multispecies biofilms. For many 
years, culture-based diagnostic microbiology has been the mainstay of CF clinical care11, however underestimat-
ing the presence of biofilms in these infections. The remarkable advances achieved with molecular approaches in 
the last decades has led to an improvement in the CF diagnosis, by often detecting previously undescribed levels 
of microbial diversity20–22,41. In parallel to the array of microbes, complex local microenvironments (containing 
gradients of nutritional/carbon sources and regions with a range of oxygen potentials) invariably exist in the CF 
airways42. Through our progressive understanding of the complexity of the CF milieu, it becomes increasingly 
apparent that the CF sociomicrobiology (i.e. how microbes assemble, how they function and how they change in 
the community) is shaped by a myriad of factors acting collectively7,40,43. Detailed and robust measures of these 
changes in biofilm communities are urgently required, and become even more critical if the activity (and possi-
bly, the further selection) of a given antibiotic treatment is dictated by the composition of the community, as has 
been recently denoted40,44,45. Using phylogenetically distinct species identified in CF samples46, we defined three 
consortia that could apparently be representative of the CF infections, encompassing the prominent pathogen P. 
aeruginosa and two lesser common species I. limosus (a gram-negative aerobe) and D. pigrum (gram-positive, fac-
ultative anaerobe)40,46. Such populations were quantitatively assessed through culture and molecular techniques 
in biofilms challenged by environments with variable oxygen and antibiotic treatment. The experimental design 
and workflow of our strategy is shown in Fig. 1.
Experimental validation of culture, q-PCR and PNA-FISH methods in planktonic popula-
tions. Prior to biofilm quantification experiments, the quantification methods were optimized and validated 
to specifically detect and differentiate P. aeruginosa, I. limosus and D. pigrum in mixed-species planktonic pop-
ulations (Fig. 2). In an earlier report47, we have already validated a multiplex PNA-FISH assay, where P. aerug-
inosa and I. limosus could be easily detected under fluorescence microscopy, by using specific designed PNA 
probes (Paer565 and Ilim569, respectively). We have also successfully applied the PNA-FISH assay combined 
with non-specific dye DAPI staining to visualize and discriminate P. aeruginosa, I. limosus and D. pigrum in 
triple-species biofilms.
For the plate count assay, a mixed-species culture containing equal proportions (~107 CFU/mL) of the three 
bacterial suspensions was monitored onto unspecific (TSA) and specific (PIA and supplemented BCSA) solid 
growth media after 24 to 48 h incubation at 37 °C (Fig. 2A,B).
Based on colony morphology, it was possible to distinguish P. aeruginosa, I. limosus and D. pigrum onto 
unspecific TSA culture medium (Fig. 2A, left image). While not recommended in CF clinical microbiology11, PIA 
showed to be highly specific for P. aeruginosa isolation, enhancing the blue-green pyocyanin pigment produced 
by this strain (Fig. 2A, centred image). Likewise, the specific recovery of I. limosus could also be improved by 
using BCSA (a selective medium strongly recommended for B. cepacia complex) supplemented with polymyxin 
B and ticarcillin48, allowing the detection of slimy whitish I. limosus colonies after extended incubation time 
(Fig. 2A, right image). CFU counts (Fig. 2B) estimated either on TSA or on selective media approximated the 
initial concentration combined for each bacterial suspension in the mixed-species liquid culture. To the authors’ 
knowledge, no specific culture medium has been reported to isolate the CF less common species D. pigrum. In 
this study, D. pigrum counts in mixed-species cultures were estimated indirectly by the difference between TSA 
counts and those enumerated by selective growth media.
Because q-PCR efficiency is highly dependent on the primers used, experimental validation of the q-PCR 
method was firstly evaluated by measuring the amplification efficiency for each set of primers designed to specifi-
cally target the 16S rRNA gene of P. aeruginosa, I. limosus and D. pigrum species (Fig. 2C). Primers efficiency was 
determined by the dilution method as well as performing a temperature gradient reaction from 50 to 65 °C, in 
order to determine the optimal primer annealing temperature. In general, the generated standard curves showed 
a linear fit with slopes between approximately −3.52 (obtained for the gene targeting I. limosus: IL_16S) and 
−3.65 (for the gene targeting D. pigrum: DP_16S), which are equivalent to 91 to 101% of reaction efficiency and 
are, therefore, within the acceptable range (90–110%)49. The optimal annealing temperature was shown to be 
58 °C, with all set of primers showing high and comparable amplification efficiencies. To prevent cross-reactivity 
with the remaining species in the consortia, the specificity of each set of primers designed for P. aeruginosa, I. 
limosus and D. pigrum was monitored by the outcome of the presence or absence of a specific 16S band visualized 
in a 1% (w/v) agarose gel (Fig. 2D). Experimental evidence showed high specificity for all pair of primers, with 
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PA_16S, IL_16S and DP_16S displaying only positive result for the presence of a specific 16S band for P. aerugi-
nosa, I. limosus and D. pigrum, respectively. Also, the presence of primer dimer or reagent contamination was not 
detected by the negative control (data not shown).
Biofilm quantification by plate count, PNA-FISH and q-PCR. Following experimental validations of 
culture and molecular techniques, dual- and triple-species biofilms were grown under AER, MAER and ANAER 
conditions and then quantified (Fig. 3). Considering the range of factors generated for this study (involving con-
sortia with different number and physiologically distinct species; environments with distinct oxygen availabili-
ties), one might expect a priori that such multifactorial heterogeneity may lead to variable outcomes in biofilm 
quantification by the different methods.
Total biofilm counts, as assessed by the different methods (Fig. 3A), were obtained by adding the counts for 
each individual population (displayed in Fig. 3B). As shown, total counts for the 6 h-old biofilms ranged between 
105 and 107 CFU/cm2 of magnitude (Fig. 3A), with PNA-FISH and q-PCR displaying the highest biofilm counts. 
Some divergences (<1 log10 counts per cm2) could be observed between plate count and PNA-FISH. Major dif-
ferences (P < 0.0001) were mostly noticed when culture or PNA-FISH counts were compared with q-PCR for the 
same oxygen environment. In addition, certain differences among counts of biofilms developed under distinct 
oxygen environments were also noticeable.
These disparities in biofilm counts are still mirrored at the species level (Fig. 3B) and become more pro-
nounced when examining the triple-species consortia. For most situations, P. aeruginosa and I. limosus showed 
the highest counts when assessed by molecular approaches. I. limosus plate counts were significantly reduced 
(~ 2.5 log10 per cm2) when compared with PNA-FISH or q-PCR counts (P < 0.0001), which enumerate I. limo-
sus populations with a difference of up to 4 log cells per cm2. Similar results were achieved for P. aeruginosa, 
that tends to reduce gradually their culture counts along with the decrease of oxygen in the environment, but 
still being detected in significantly greater numbers by PNA-FISH and q-PCR. These outcomes underline the 
notion that using exclusively a single method may not provide detailed/true insight into the biofilms composi-
tion and even render for misleading outcomes when elucidating the microbial interactions within the consor-
tia. Intriguingly, D. pigrum counts estimated by q-PCR were markedly affected in comparison with respective 
quantification by PNA-FISH or culture (P < 0.0001 for most cases). This inconsistency in quantification was 
noticed for both dual- (P. aeruginosa/D. pigrum) and triple-species biofilms (P. aeruginosa/I. limosus/D. pigrum). 
While culture and PNA-FISH methods allowed to assess D. pigrum in great abundance (approximating 6 log10 
Figure 1. Experimental design and workflow. Two- and triple-species biofilms involving P. aeruginosa,  
I. limosus, and D. pigrum developed under aerobic, microaerophilic, and anaerobic environments and the 
triple consortia exposed to antibiotics were assessed through culture (plate count) and molecular (q-PCR and 
PNA-FISH) methods. In culture-based method, individual biofilm populations were quantified by unspecific 
and selective growth media. Regarding q-PCR, DNA extracted from the biofilm-cells was amplified by 
using specific designed oligonucleotide primers and individual biofilm populations quantified by previous 
established standard curves (plotting CFU/mL vs Ct for pure cultures). A multiplex PNA-FISH assay with an 
additional staining step with DAPI was performed ex situ, using specific PNA probes - Paer565 and Ilim569 - 
previously developed and optimized46 and bacteria were then estimated using an epifluorescence microscope. 
Experimental validation was performed for each technique before biofilm quantification experiments. 
Abbreviations: PA = P. aeruginosa, IL = I. limosus, DP = D. pigrum, AER = aerobic, MAER = microaerophilic, 
ANAER = anaerobic, TOB = tobramycin, CIP = ciprofloxacin, ATM = aztreonam.
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cells per cm2) in biofilms grown under all oxygen environments (some examples of PNA-FISH images are in 
Supplementary Fig. S1), q-PCR estimates D. pigrum between 3 to 4 log10 counts per cm2 (P < 0.0001). Despite 
showing significant differences in individual population counts, both culture and molecular techniques have 
ascertained for P. aeruginosa the highest absolute numbers in the consortia, which was observed for most cases.
In brief, our findings highlight large discrepancies between culture and molecular methods in detecting and 
quantifying cells encased in biofilms. As we cannot precisely define the molecular mechanisms that are beyond 
such incongruities, it is conceivable to suggest that the external environmental conditions may have induced 
changes in the dynamics (e.g. microbial composition, function, metabolic processes) of the communities, with 
the level of complexity/heterogeneity generated inside the biofilms ultimately having potential implication in the 
reliability and effectiveness of the different methods (e.g. at gene expression and amplification levels in q-PCR 
method; at limited PNA probe diffusion into the consortium; at limiting growth on solid medium). For instance, 
we could notice that biofilms formed under AER, MAER and ANAER conditions showed apparently great 
D. pigrum abundance, which was ascertained by plate count and PNA-FISH. We may speculate that the dis-
proportionate amount of D. pigrum cells in the consortia may be associated to a limited effectiveness of DNA 
extraction step and thus presenting a limited yield by q-PCR. The process of DNA extraction is often deemed as a 
critical step, as cell lysis efficiency might not be equal for all the microbial cells in a sample. DNA recovery differs 
both from the bacterial species and from the type of the sample50,51. D. pigrum is a Gram-positive bacterium, 
arranged in pairs, tetrads and/or clusters52,53, which can make cell disruption arduous and consequently impair 
nucleic acid release. After testing different approaches (including several commercially available kits) attempting 
to extract DNA from planktonic cultures, acceptable DNA yields (in terms of concentration and purity) were 
only achieved after a cell lysing pre-treatment combining chemical and mechanical lysis (a procedure generally 
used to lyse yeast cells). But we believed that DP DNA extraction could be likely compromised when transposed 
directly to biofilms. In order to confirm our theory, monospecies biofilm counts were estimated by different tech-
niques (culture, PNA-FISH, q-PCR and DAPI), with D. pigrum counts being drastically affected by q-PCR (where 
Figure 2. Validation of culture and q-PCR methods. (A) Discrimination of P. aeruginosa, I. limosus and  
D. pigrum colonies on unspecific (TSA) and on specific culture medium (PIA and supplemented BCSA). PIA 
was specific for P. aeruginosa and BCSA supplemented with 100 mg/L ticarcillin and 300 000 IU/L polymyxin B 
was specific for I. limosus after extended incubation time; (B) Bacterial counts (expressed as means ± standard 
deviations (SDs) CFU/mL for three independent assays) obtained on TSA on specific selective media. Bacterial 
counts were monitored on solid growth media after incubation at 37 °C for 24–48 h from a mixed-species 
planktonic culture, containing equal proportions (~107 cells/mL) of each bacterial suspension; (C) q-PCR 
amplification efficiency, measured by the efficiency of each set of primers designed for specific detection of  
P. aeruginosa (PA_16S), I. limosus (IL_16S) or D. pigrum (DP_16S). Amplification efficiency (E), expressed as 
percentage, was determined from the slope of the standard curve plotting the log of the initial template copy 
number vs Ct (for each set of primers, the standard curves were repeated at least, twice, and the means ± SDs 
of the obtained amplification efficiencies are illustrated); (D) Experimental specificity test determined for each 
set of primers specifically designed for each species. Primer specificity was monitored by the outcome of the 
presence or absence of a specific 16S band visualized in a 1% (w/v) agarose gel. (+) indicates presence of band; 
(−) is indicative of absence of band. Abbreviations: PA = P. aeruginosa, IL = I. limosus, DP = D. pigrum.
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the reduction achieved, in average, 3.8 log10 cells per cm2) when compared with culture or DAPI enumerations 
(P < 0.0001) (see Supplementary Fig. S2).
As of yet, no molecular tests suitable for comprehensive analysis of individual populations in biofilms are 
completely exploited (although potentially suitable technologies and instrumentation already exist), assay devel-
opment and validation would have to be undertaken. Our results prove that validating a method for planktonic 
microorganisms is not sufficient if the final application is in biofilms. It is hard, however, to conceive a method 
that can be fully reliable for all physiological states that cells can be found in biofilms. The problematic here is that 
validation would have to be performed for every specific situation of biofilm assessment (including time, condi-
tions, etc.), which is time-consuming and potentially unpractical. A brief appreciation on biofilm quantification 
studies suggests that most do not refer a priori calibration and/or validation of the methods used for or include 
optimization just for cells in suspension13,26,34,36–38,54–57.
Quantification of biofilms following antibiotic treatment. Following biofilm development under the 
different oxygen environments, the next stage was to appraise for the biofilm changes promoted by the antibiotic 
treatment. Biofilms involving the three species were exposed for additional 24 h to sub-MBEC doses of three CF 
relevant antibiotics: TOB (at 128 mg/L), CIP (2 mg/L) and ATM (2 mg/L) and further quantified by means of 
culture-dependent and –independent methods (Fig. 4).
Overall, total cells ascertained by the different methods remained relatively constant for most biofilms before 
(Fig. 3A) and after antibiotic treatment (Fig. 4A). These findings are in agreement with previous studies, that 
showed minimal changes in bacterial counts following antibiotic treatment12,58,59, therefore illustrating that the 
overall bacterial burden remains unchanged despite treatment. Similar to that observed for untreated biofilms, 
the discrepancies among culture, PNA-FISH and q-PCR counts after antibiotic treatment were more notorious 
while assessing the individual populations (Fig. 4B). To focus on the differences in individual counts ascertained 
by the different methods, see Supplementary Fig. S3.
Figure 3. Biofilm quantification by plate count, PNA-FISH and q-PCR. (A) Total counts, expressed as CFU 
per cm2, estimated for biofilms formed by P. aeruginosa, I. limosus and D. pigrum developed under aerobic, 
microaerophilic and anaerobic conditions; (B) Populations of P. aeruginosa, I. limosus and D. pigrum in dual- 
and triple-species biofilms, estimated by the different methods. For each biofilm/condition, means ± SDs for 
bacterial counts are illustrated (for plate counts, three independent experiments were performed: 18 ≤ n ≤ 24; 
for PNA-FISH, two to three independent experiments were performed: 10 ≤ n ≤ 30; for qPCR, two to four 
independent experiments were performed: 6 ≤ n ≤ 9). Significant differences (P < 0.05) are indicated as 
follows: (*) significantly different total counts between oxygen environments; (#) significantly different P. 
aeruginosa counts between oxygen environments; (α) significantly different I. limosus counts between oxygen 
environments; (γ) significantly different D. pigrum counts between oxygen environments; (a) significantly 
different from plate counts; (b) significantly different from PNA-FISH counts; (c) significantly different 
from q-PCR counts. Abbreviations: PA = P. aeruginosa, IL = I. limosus, DP = D. pigrum, AER = aerobic, 
MAER = microaerophilic, ANAER = anaerobic.
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It was noticeable that the highest bacterial numbers were detected by PNA-FISH and/or by q-PCR (Fig. 4B). 
Similar findings were already observed for untreated biofilms. Biofilm composition showed to be highly variable, 
with fluctuations in population sizes being dependent on the antibiotic used. An increasing body of evidence has 
highlighted the effect of antibiotic treatment in the composition of the communities40,44,60, with recent reports 
even showing changes on other members of the airways microbiota beyond P. aeruginosa exerted by CIP and 
TOB therapies61. In this study, however, our surprise lies on the disparities in individual population‘ abundances 
relying on the method used to characterize the individual populations. And if these incongruences are well noto-
rious in our restricted biofilm model size (of only three bacterial species), we can even speculate for a more 
complicated scenario when assessing a broader community, which truly reflects most polymicrobial infections. 
In brief, we particularly discerned a sharp decline in I. limosus quantification by culture after antibiotic inter-
vention (even displaying negative culture in CIP-exposed biofilms). However, this decay was not observed when 
quantitated by molecular tools, with both still detecting I. limosus in significantly higher numbers than culture 
(Fig. 4B). Once again, these findings strictly reflect that culture techniques solely may not prove to be the most 
reliable method to undertake biofilm composition analysis, particular upon antibiotic stress, with studies identi-
fying either bacteria that can enter a VBNC state62,63 or that are below the detection limit of culture12. In addition, 
for the case of fastidious and so potentially difficult to culture organisms, as is I. limosus, cultivating these species 
upon antibiotic pressure can be even more problematic.
Analogously to what was observed for untreated biofilms, q-PCR counts obtained for D. pigrum popula-
tions were still significantly disturbed in comparison with counts from culture and PNA-FISH (P < 0.0001 for 
most cases) which, as has been suggested, is likely related to the ineffectiveness of DNA extraction in D. pigrum 
biofilms.
Irrespective to the technique used to characterize the consortia, P. aeruginosa was apparently the most dom-
inant population ascertained by all methods, a finding also observed in the case of untreated biofilms. These 
results suggest that, although showing to be inconsistent in giving absolute bacterial counts in biofilms, these very 
Figure 4. Biofilm quantification following antibiotic treatment. (A) Total counts, expressed as CFU per cm2 
and (B) Populations of P. aeruginosa, I. limosus and D. pigrum within the defined triple-species biofilms 
(PA/IL/DP) exposed to 128 mg/L tobramycin, 2 mg/L ciprofloxacin and to 2 mg/L aztreonam under aerobic, 
microaerophilic and anaerobic conditions for 24 h. For each biofilm/condition, means ± SDs for bacterial 
counts are illustrated (for plate counts, three independent experiments were performed: 18 ≤ n ≤ 24; for PNA-
FISH, two to three independent experiments were performed:10 ≤ n ≤ 30; for qPCR, two to four independent 
experiments were performed: 6 ≤ n ≤ 9). Significant differences (P < 0.05) are indicated as follows: (*) 
significantly different total counts between oxygen environments; (#) significantly different P. aeruginosa counts 
between oxygen environments; (α) significantly different I. limosus counts between oxygen environments; 
(γ) significantly different D. pigrum counts between oxygen environments; (a) significantly different from 
plate counts; (b) significantly different from PNA-FISH counts; (c) significantly different from q-PCR counts. 
Abbreviations: PA = P. aeruginosa, IL = I. limosus, DP = D. pigrum, AER = aerobic, MAER = microaerophilic, 
ANAER = anaerobic, TOB = tobramycin, CIP = ciprofloxacin, ATM = aztreonam.
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different methods can be employed, with some level of confidence, to detect abundant organisms in a polymi-
crobial community. As the most prominent organism detected in CF polymicrobial consortia, it is not therefore 
surprising that P. aeruginosa has been the major focus in CF antibiotic therapy64–66. However, it is not possible 
to preclude that less-abundant species cannot act as significant contributors for a more severe and recalcitrant 
infection, as it has been earlier reported for IL and DP10,40.
The P. aeruginosa, I. limosus and D. pigrum abundances in biofilms assessed by the different quantifica-
tion methods can be better visualized through their relative bacterial distributions in the consortia (Fig. 5). 
Inconsistent distributions in the biofilm individual populations were well evident while using different quan-
tification techniques. Accordingly, a species can be determined as being the dominant/major in a biofilm sam-
ple, but only detected as a merely “contaminant” when assessed by a different quantification method. It was the 
case of q-PCR, which seems to select only for one species (P. aeruginosa) or two (P. aeruginosa and I. limosus) 
(with the relative percentage of DP in the whole consortia below 1.3%) when analysing P. aeruginosa/D. pigrum 
(Fig. 5A) and triple biofilms before (Fig. 5A) and following antibiotic exposure (Fig. 5B). Again, these inadequa-
cies amongst biofilm quantification data strongly emphasises the need for a complete and rigorous calibration of 
the methods used for assessing the consortia.
It was noteworthy in this study that, despite the incongruities among biofilm quantification data, molecular 
techniques often displayed higher aptitude and sensitivity to afford greater counts for biofilm individual popu-
lations, comparing with conventional culture. In addition to q-PCR, which has been a widely used technique in 
analysing environmental and clinical microbiological samples, epifluorescence microscopy based methods also 
offer a faster and reliable alternative for monitoring polymicrobial biofilm communities. In particular, PNA-FISH 
effectively extends epifluorescence microscopy, allowing for a rapid discrimination, location and/or enumeration 
of bacterial populations in polymicrobial communities40,47,67–74. In our study, to make biofilm-cells counts easy 
and homogeneous (which likely facilitates in the case of thick and more dense biofilms), PNA-FISH assay was 
performed ex situ to quantitatively monitor bacterial populations in the multispecies consortia69,70.
Despite the potential of the molecular tools to circumvent some of the culture flaws, frequently providing a 
more rapid and sensitive assessment of the species present in polymicrobial infections, it must be recognized that 
these techniques can also introduce potential bias. For instance, q-PCR requires designing primer sequences 
for each species present in the sample. As we know which bacteria were included in our consortia, we only need 
to design sets of oligonucleotide primers to specifically target those species. But with the literally thousands of 
microbes existing in most polymicrobial infections, constructing thousands of primers for each analysis is inef-
ficient, costly and currently impractical75. Furthermore, prediction need to be made as to which agent is likely 
Figure 5. Relative distributions of the bacterial populations within biofilms, determined by culture-based and 
molecular methods. (A) Distributions for P. aeruginosa, I. limosus and D. pigrum populations in dual- and 
triple-species biofilms before antibiotic treatment; (B) and for the triple biofilms following antibiotic treatment 
with 128 mg/L tobramycin, 2 mg/L ciprofloxacin and 2 mg/L aztreonam, under aerobic, microaerophilic and 
anaerobic environments. For each condition/biofilm, means of the relative percentages of the biofilm individual 
populations are illustrated for two to four independent assays. Abbreviations: PA = P. aeruginosa, IL = I. 
limosus, DP = D. pigrum, AER = aerobic, MAER = microaerophilic, ANAER = anaerobic, TOB = tobramycin, 
CIP = ciprofloxacin, ATM = aztreonam.
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to be associated with a particular infection76. Also, FISH presents numerous advantages when compared with 
culture-dependent techniques and even with q-PCR (e.g. avoiding DNA extraction or PCR processes), but has 
several limitations. Likewise to PCR, knowledge of the nucleotide sequence of the target organisms in the samples 
is needed to design new probes which, together with the optimization of the hybridization conditions makes the 
processes time-consuming and labor-intensive47,77. Also, the efficiency of the hybridization might be influenced 
by the physiological state of the cells47,78. To conclude, the bulk cost of the technique is particularly related with 
the commercial value of PNA probes, which are relative expensive67, likely supporting its limited use in routine 
microbial diagnosis in many clinical microbiology laboratories.
Conclusions
The importance of examining in detail the microbial composition of biofilms is critical while we now recognize 
the truly polymicrobial nature of many biofilm infections, ranging from clinic (lung/respiratory tract79, oral cav-
ity80, skin81, gut82, stomach83, urinary tract84) to environmental/industrial sources (marine sediments85, industrial 
bioreactor, sludge86). Providing detailed insights into the diversity and abundances of inhabiting microbes is of 
great importance for a better understanding on the role that polymicrobial biofilms may play in their natural 
context alongside with an improvement in the likelihood of treatment success.
This study observed relevant inconsistencies between conventional culture and molecular tools in detecting 
and quantifying bacterial populations inhabiting in a biofilm. Based on our findings, we recommend using at least 
two, but preferentially three methodological approaches, to analyse complex polymicrobial communities such as 
the ones in CF. It is envisioned that combining more than one methodological approach will be valuable to cir-
cumvent the caveats of each technique alone, tailoring a more complete picture of a broad range of polymicrobial 
biofilm communities, ultimately unlocking accurate microbiome-associated treatment decisions and potentially 
yielding novel avenues aimed at effectively controlling/eradicating detrimental polymicrobial biofilms.
Materials and Methods
Biofilm formation and preparation for quantification analysis. Two- and triple-species biofilms 
encompassing the major pathogen P. aeruginosa (UCBPP-PA14) and two less typical species - I. limosus (strain 
M53, isolated from CF sputum), and D. pigrum (CIP 104051 T, purchased from Institute Pasteur Collection, 
Paris, France) - identified in CF infections87, were developed for 6 h under environments with distinct oxygen 
availabilities - aerobic (AER), microaerophilic (MAER) and anaerobic (ANAER) - using procedures described in 
earlier reports40,88.
The triple consortia were then exposed to 128 mg/L tobramycin (TOB), 2 mg/L ciprofloxacin (CIP) and to 
2 mg/L aztreonam (ATM) (all from Sigma-Aldrich, St. Louis, MO, USA). TOB, CIP and ATM are typically used 
as first-line treatments to control or eradicate P. aeruginosa CF pulmonary infections65. The selected antibiotic 
concentrations were sub-therapeutic (below values obtained for Minimum Biofilm Eradication Concentration, 
MBEC), determined elsewhere40 to ensure that biofilms were not completely eradicated and allowing to address 
changes in biofilm microbial compositions. Stock antibiotic solutions were prepared at 1000 mg/L, following 
the manufacturer’s instructions. After biofilm formation, the wells were rinsed with sterile distilled water to 
remove non-adhered cells and the triple-species biofilms were exposed to freshly working antibiotic solutions 
(prepared by diluting the antibiotic from stock solution in cation-adjusted Mueller-Hinton broth (CAMHB) until 
the desired final concentration). Plates were then incubated for 24 h at 37 °C, under AER, MAER and ANAER 
conditions. The experimental design and workflow of our strategy for biofilm quantification analysis is outlined 
in Fig. 1.
Assessment of individual populations in biofilms. After discarding the planktonic cell fractions 
(supernatant) from untreated and antibiotic-treated biofilms, the wells were rinsed twice and microbial composi-
tion of biofilms was analyzed throughout culture- and molecular-based techniques:
Plate count (culture-based) method. After the rinsing step, wells were filled with 0.9% (w/v) saline solution 
(NaCl; J. T. Baker, The Netherlands) and biofilms were detached by sonication using an ultrasound bath (Sonicor, 
model SC-52, UK) operating at 50 kHz, during 10 min and then resuspended by pipetting up and down, as 
recently described40. After sonication, 1 mL of biofilm suspension was transferred to an Eppendorf tube and 
vortexed vigorously for 30 s. Serial 10-fold dilutions from each biofilm sample were made on saline solution and 
10 μL drops of each dilution were plated onto TSA and on selective agar media to discriminate each bacterial 
population in the consortia. For PA quantification, plates containing Pseudomonas isolation agar (PIA; Sigma) 
were used. For I. limosus isolation, Burkholderia cepacia selective agar, (BCSA; Oxoid Ltd, Hampshire, UK) sup-
plemented with 300 000 IU/L polymyxin B (Biochrom, Berlin, Germany) and 100 mg/L ticarcillin (Sigma) was 
employed. Estimation of D. pigrum in the dual- and triple-species biofilms was based on the difference between 
the average total cell number (determined by counts in TSA) and the average number of bacteria, obtained from 
selective culture media, presented in the consortia. To validate the culture method, a mixed-planktonic suspen-
sion containing the three bacteria combined in equal proportions (at ~107 cells/mL) was monitored on TSA and 
on selective media.
PNA-FISH multiplex assay. A multiplex FISH assay using two specific PNA probes, Paer565 and Ilim569, pre-
viously developed, optimized and validated for P. aeruginosa and I. limosus detection, respectively47, was fol-
lowed. At the end of the hybridization procedure, an additional staining step with 4′, 6-diamidino-2-phenylindole 
(DAPI; Sigma) was carried out to identify the third organism (D. pigrum).
PNA-FISH assay was performed ex situ, according with previous procedures69,70. Briefly, after rinsing bio-
films, the wells were scraped in 1 mL of ultrapure sterile water. The resulting biofilm-cells suspensions were then 
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pipetted up-and-down, transferred to an Eppendorf tube and vortexed for 30 s at maximum speed. Afterwards, 
20 μL of each biofilm sample were spread in 8 mm well diagnostic glass slides (ThermoScientific, Braunschweig, 
Germany) and let to air-dried prior to fixation. The fixation, hybridization and the probes washing procedures 
were strictly followed as described before47. At the end, the smears were allowed to air dry, immersed in 20 μL of 
DAPI (40 μg/mL) for 10 min and incubated at room temperature in the dark. Prior to microscopy, samples were 
mounted with one drop of non-fluorescent immersion oil (Olympus, Tokyo, Japan) and analysed using an epiflu-
orescence microscope (Olympus BX51) coupled with a DP72 digital camera and three sets of filters (DAPI – 360-
370/420; FITC – 470–490/520, sensitive to detect Alexa Fluor 488 molecule attached to the Ilim569 probe; and 
TRITC – 530–550/590, sensitive to detect Alexa Fluor 594 molecule attached to the Paer565 probe) (Olympus 
Portugal SA, Porto, Portugal). All images were acquired using the Olympus cellSens software. A total of 10 to 30 
fields with an area of 5671,3 μm2 were counted and the average was used to estimate the P. aeruginosa, I. limosus 
and D. pigrum cells per cm2. At least, two independent experiments were performed for each condition.
Quantitative Real-time PCR (q-PCR) assay. First, 20–22 bp oligonucleotide primers for the detection of 16S 
rRNA reference genes were designed using the Primer3 web-based software (http://frodo.wi.mit.edu/)89, hav-
ing P. aeruginosa PAO1 (PubMed accession number NC_74828.1), I. limosus M53 (PubMed accession number 
JF803524.1) and D. pigrum NCFB 2975 (PubMed accession number X70907.1) genome as templates (Table 1). 
Potential candidates for PCR primers were compared to the aligned SSU-rRNA database of the Ribosomal 
Database Project II (RDP-II) using the PROBE MATCH utility90 and were compared to all available 16S rRNA 
sequences by using the BLAST database search program (http://blast.ncbi.nlm.nih.gov/Blast.cgi)90.
Assessment of primers efficiency and specificity. The q-PCR amplification efficiency was obtained by 
measuring the efficiency of each primer pair, which was determined through the dilution method and established 
by means of a calibration curve91. Briefly, for each species, serial dilutions from a genomic DNA (gDNA) sample 
of known concentration (50 ng/μL) were made in RNAse free water and amplification of standard dilution series 
was followed by performing as described in the sections below, under temperature gradient reaction ranging 
from 50 to 65 °C. The standard curve was generated by plotting the log of the initial template copy number against 
the cycle threshold (Ct, i.e. the threshold cycles in which exponential amplification of PCR products was first 
detected) generated for each dilution. Amplification efficiency (E), expressed as percentage, was then determined 
from the slope of the log-linear portion of the calibration curve, as follows: E = 10−1/slope − 1. At least 4 points 
were used to construct each curve and each gDNA concentration was run in duplicate. Because at 58 °C, all set of 
primers had the best and more similar efficiencies value, this annealing temperature was used in the q-PCR pro-
tocol for further assays. The specificity of each set of primers was evaluated by visualizing the presence or absence 
of specific 16S band in a 1% (w/v) agarose gel (electrophoresis was carried-out at 90 V for 45 min) for each species 
and also observing for non-specific binding (e.g. primer dimer formation). Furthermore, a melting curve analysis 
was performed for all primer sets, in all experiments, to ensure a single peak, indicative of primer specificity.
Extraction of genomic DNA from biofilms. In order to extract gDNA from biofilms, 24 wells from 
24-well plates were scraped per condition and the biofilm disrupted-cells (concentrated in 3 mL sterile distilled 
water) were collected in 15 mL polypropylene conical tubes. To remove extracellular DNA, the biofilm matrix was 
extracted by sonicating the biofilm samples in ice in an ultrasonic processor (Cole-Parmer, IL, USA) for 30 s at 
30% amplitude, followed by a vortexing step of 30 s and centrifugation (5000 × g; 10 min)92. To ensure that son-
ication do not interfere with cell cultivability, CFU from biofilm samples were confirmed after sonication (data 
not shown). After discarding the supernatant, the biofilm-cell pellet was resuspended in 200 μL of lysis buffer 
(containing 2% (v/v) triton X-100 (at pH 10; Sigma-Aldrich, St. Louis, MO, USA), 1% (w/v) sodium dodecyl 
sulphate (Sigma), 100 mM NaCl, 10 mM Tris-HCl (at pH 8.0; Sigma) and 1 mM disodium EDTA (Sigma) and 
transferred to a sterile Eppendorf tube containing 0.3 g acid-washed glass beads (150–212 μm diameter) (Sigma). 
Afterwards, 200 μL of phenol:chloroform:isoamyl alcohol 25:24:1 (Sigma) were added and the samples vortexed 
vigorously for 3 min. Then, 200 μL of TE Buffer (containing 10 mM Tris-HCl at pH 8.0 and 1 mM disodium 
EDTA) were added and centrifuged (12000 × g; 5 min). The aqueous phase was transferred to a new DNAse/
RNAse-free Eppendorf tube and after adding 1 mL of absolute ethanol (Fisher Scientific, Leicester, UK) (and 
mixed by inversion), the gDNA was allowed to precipitate by incubating the samples at −20 °C (overnight). 
Afterwards, the samples were centrifuged (12000 × g; 3 min) and the pellet was resuspended in 400 μL of TE 
Buffer. Then, 30 μL of RNAse A (at 1 mg/mL) were added, and the samples were incubated for 5 min at 37 °C, to 
remove any RNA contaminants. After incubation, 10 μL of 3 M sodium acetate and 1 mL absolute ethanol were 
Primer Sequence (5′−3′) Target species Locationa Product size (bp)
PA_16 S_FW CTCAGACACAGGTGCTGCAT
P. aeruginosa
1031–1050
130
PA_16S_RV CACCGGCAGTCTCCTTAGAG 1141–1160
IL_16S_FW CGACGATGATGACGGTAGTG
I. limosus
341–360
167
IL_16S_RV AATGCAGTTCCCAGGTTGAG 488–507
DP_16S_FW TGATTGATTAGTGGCGAACG
D. pigrum
77–96
221
DP_16S_RV CACCCTCTCAAGTCGGCTAC 278–297
Table 1. Sequences of oligonucleotide primers to target 16S rRNA reference genes used in this work. aPosition 
and size relative to 16S rRNA sequence of the template organisms.
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added. The samples were mixed by inverting the tubes and centrifuged for 23 min (12000 × g). Lastly, the super-
natant was discarded and the pellet was allowed to air-dry, before resuspended it in 30 μL with RNAse free water 
(Cleaver Scientific Ltd, Warwickshire, UK). The concentration and purity of the total gDNA was spectrometri-
cally assessed using a NanoDrop 1000™ (Thermo Scientific, Waltham, MA, US). The absorbance ratios A260/A280 
were used as indicators of protein contamination and A260/A230 as indicators of polysaccharide, phenol, and/or 
chaotropic salts contamination93. The integrity of the total gDNA was assessed by visualization of the 16S banding 
pattern in a 1% (w/v) agarose gel. Total gDNA extractions were performed two to four times and samples were 
kept at −20 °C before amplification.
Biofilm DNA amplification in q-PCR. The amplification reactions were carried out in a total volume of 
10 μL, which consisted of 2 μL of DNA samples and 8 μL of the master mixture. The latter contained 500 nM 
of each primer, 5 μL of 2 × of the commercial q-PCR master mix SsoFast™ EvaGreen® Supermix (Bio-Rad, 
Hercules, CA, USA). Amplifications were performed on a CFX96TM thermal cycler (Bio-Rad), comprising 1 cycle 
of 2 min at 98 °C (hot start) followed by 40 cycles of 98 °C for 5 s for denaturation. Annealing step was performed 
for 5 s at 58 °C and extension was made at 65 °C to 95 °C for 5 s (with temperature increments of 1 °C). The q-PCR 
products were analyzed by melting curves for unspecific products or primer dimer formation. Fluorescence was 
measured after each cycle. Each assay was carried out in duplicate and the average Ct value from each duplicate 
was used for analysis.
Quantification by q-PCR. To quantify the individual populations in mixed species biofilms, standard 
curves were constructed for pure cultures of P. aeruginosa, I. limosus and D. pigrum. Basically, several colonies 
of fresh subcultures of each organism were collected and suspended in TSB. Serial 10-fold dilutions were made 
from each culture and dilution samples were plated onto TSA and plates incubated at 37 °C for 24–48 h. Colonies 
were counted in order to calculate the number of CFUs per dilution tube. The average of three replicates was 
determined and data was presented as CFU per mL. One milliliter from each dilution tube was subjected to 
gDNA extraction as described above, and samples were further analyzed concomitantly by q-PCR. For the con-
struction of standard curves for each of the three bacteria, the Ct values were plotted against CFU number from 
the corresponding dilution sample through a tendency line. The standard curves were used to determine the 
CFU numbers within biofilms by converting Ct values obtained for consortia to CFU numbers by the tendency 
line equation for each organism. This approach was used because for biofilms it is easier to understand results in 
actual CFU numbers than in DNA concentration or copy numbers. Additionally, results are easily compared with 
those obtained by culture.
Differences in bacterial counts ascertained by culture and molecular methods. To measure the 
variations in P. aeruginosa, I. limosus and D. pigrum cell numbers within biofilms ascertained by culture and 
molecular methods, ΔLog10 cells/cm2 was defined as the difference between the number of cells detected by assay 
A and by assay B, respectively:
Log cells/cm N N10
2
assay A assay BΔ = −
where N is the value of mean log10 CFU/cm2 obtained for each bacterial population in the biofilm. Therefore, 
ΔLog10 cells/cm2 values were determined for each species in the biofilm and for each pair of assays (Culture vs 
PNA-FISH; Culture vs q-PCR and PNA-FISH vs q-PCR), and then interpreted as follows: a ΔLog10 cells/cm2 
value equal to 0 indicates no variation in bacterial counts estimated by assay A and B; a positive ΔLog10 cells/
cm2 value indicates higher bacterial counts estimated by assay A; a negative ΔLog10 cells/cm2 indicates higher 
bacterial counts estimated by assay B.
Statistical analysis. Graph production and data were analyzed using Prism Version 7.0a for Macintosh. 
Unless otherwise stated, means ± SDs are illustrated for each biofilm/condition. The number of independent 
assays (technical replicates) ranged between two and four, depending on the method. The number of biological 
replicates (n) in each independent assay was between 6 and 30, as stated in each figure legend. In general, for plate 
counts, three independent experiments were performed: 16 ≤ n ≤ 24; for PNA-FISH, two to three independent 
experiments were performed: 10 ≤ n ≤ 30; for qPCR, two to four independent experiments were performed: 
6 ≤ n ≤ 9. One-way or two-way analysis of variance (ANOVA) tests were used to investigate significant differences 
between independent groups of data. A Tukey correction was applied to the p value to account for multiple com-
parisons of data. Differences were considered statistically significant for P values < 0.05.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
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